Rchr
J-GLOBAL ID：201801000403300177
Update date: Nov. 17, 2024
Fujiwara Koichi
フジワラ コウイチ | Fujiwara Koichi
Affiliation and department：
Research field (1)：
Pharmaceuticals - chemistry and drug development
Research theme for competitive and other funds (3)：
- 2021 - 2023 炎症収束性脂質レゾルビンE2の安定化を基盤とした高活性等価体の創出
- 2019 - 2023 高分子間相互作用を制御する合成機能分子を論理的・効率的に創出する方法論の確立
- 2019 - 2021 Development of resolvin analogues as a metabolically stable equivalent
Papers (19)：
-
Ayaka Hamaguchi, Hayato Fukuda, Koichi Fujiwara, Tomofumi Harada, Keijo Fukushima, Satoshi Shuto, Hiromichi Fujino. Individual resolvin E family members work distinctly and in a coordinated manner in the resolution of inflammation. Prostaglandins & other lipid mediators. 2023. 168. 106759-106759
-
Masaki Gomi, Yu Sakurai, Minami Sato, Hiroki Tanaka, Yumi Miyatake, Koichi Fujiwara, Mizuki Watanabe, Satoshi Shuto, Yuta Nakai, Kota Tange, et al. Delivering mRNA to Secondary Lymphoid Tissues by Phosphatidylserine-Loaded Lipid Nanoparticles. Advanced Healthcare Materials. 2022. 2202528-2202528
-
Mizuki Watanabe, Makoto Nagata, Ryohei Doi, Mai Uemura, Nanase Ochiai, Wataru Ichinose, Koichi Fujiwara, Yoshihiro Sato, Tomoshi Kameda, Koh Takeuchi, et al. Helix-forming aliphatic homo-δ-peptide foldamers based on conformational restriction effects of cyclopropane. Organic & Biomolecular Chemistry. 2022. 21. 5. 970-980
-
Shota Arai, Koichi Fujiwara, Masahiro Kojima, Haruka Aoki-Saito, Masakiyo Yatomi, Tsugumichi Saito, Yasuhiko Koga, Hayato Fukuda, Mizuki Watanabe, Shigeki Matsunaga, et al. Design and Synthesis of Cyclopropane Congeners of Resolvin E3, an Endogenous Pro-Resolving Lipid Mediator, as Its Stable Equivalents. The Journal of Organic Chemistry. 2022. 87. 15. 10501-10508
-
Haruhiro Higashida, Kazumi Furuhara, Olga Lopatina, Maria Gerasimenko, Osamu Hori, Tsuyoshi Hattori, Yasuhiko Hayashi, Stanislav M. Cherepanov, Anna A. Shabalova, Alla B. Salmina, et al. Oxytocin Dynamics in the Body and Brain Regulated by the Receptor for Advanced Glycation End-Products, CD38, CD157, and Nicotinamide Riboside. Frontiers in Neuroscience. 2022. 16
ｍore...
MISC (6)：
-
高島悠太, 山崎祐季, 佐藤優希菜, 植村麻衣, 松井耕平, 藤原広一, 渡邉瑞貴, 周東智. Development of membrane-permeable cyclic peptides based on conformational restriction using cyclopropane. 日本薬学会年会要旨集(Web). 2022. 142nd
-
林真由, 甘利穂乃花, 太田克美, 藤原広一, 渡邉瑞貴, 浅井章良, 周東智. 1,2,3-三置換シクロプロパンを骨格とするSTAT3阻害剤の創製研究. 反応と合成の進歩シンポジウム講演要旨集. 2022. 48th
-
田中伸英, 村上侑斗, 平島洸基, 福田隼, 藤原広一, 渡邉瑞貴, 室本竜太, 松田正, 周東智. 抗炎症脂質レゾルビンE2の1,4,7-トリエン-ベンゼン置換による安定等価体の創製研究. 反応と合成の進歩シンポジウム講演要旨集. 2022. 48th
-
坂下遼太郎, 桑原智希, 藤原広一, 渡邉瑞貴, 周東智. Study of Bcl-2 Family Protein Inhibitors Based on the Spirocyclopropane Peptidomimetics. 複素環化学討論会講演要旨集. 2021. 50th
-
Masakiyo Yatomi, Yasuhiko Koga, Haruka Saito, Makiko Sato, Hiroaki Tsurumaki, Kenichiro Hara, Noriaki Sunaga, Toshitaka Maeno, Hiroyuki Ikeda, Hayato Fukuda, et al. Resolvin E3 reduces profibrotic factor production from macrophages leading to tissue homeostasis. EUROPEAN RESPIRATORY JOURNAL. 2020. 56
ｍore...
Professional career (1)：
Return to Previous Page
